The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin- 8 receptors CXCR-1 and CXCR-2

Blood

Volumn 90, Issue 11, 1997, Pages 4588-4597

  Ludwig, Andreas ^a   Petersen, Frank ^b   Zahn, Stefan ^b   Götze, Otto ^b   Schröder, Jens Michael ^b   Flad, Hans Dieter ^b   Brandt, Ernst ^b  

^a RESEARCH CENTER BORSTEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8 RECEPTOR;

ARTICLE; DESENSITIZATION; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; MEDIATOR RELEASE; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR AFFINITY; RECEPTOR DOWN REGULATION; STEM CELL;

EID: 0030694590     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.11.4588.4588_4588_4597     Document Type: Article

References (50)

1. Hébert C, Baker J: Interleukin-8: A review, Cancer Invest 11:743, 1993
2. Zwahlen R, Walz A, Rot A: In vitro and in vivo activity and pathophysiology of human interleukin-8 and related peptides. Int Rev Exp Pathol 34B:27, 1993
3. Baggiolini M, Dewald B, Moser B: Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv Immunol 55:97, 1994
4. Brandt E, Van Damme J, Flad H-D: Neutrophils can generate their activator neutrophil-activating peptide 2 by proteolytic cleavage of platelet-derived connective tissue-activating peptide III. Cytokine 3:311, 1991
5. Härter L, Petersen F, Flad H-D, Brandt E: Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils: Requirement for proteolytic formation of the neutrophil-activating peptide 2. J Immunol 153:5698, 1994
6. Brandt E, Ernst M, Loppnow H, Flad H-D: Characterization of a platelet derived factor modulating phagocyte functions and co-operating with interleukin 1. Lymphokine Res 8:281, 1989
7. Walz A, Baggiolini M: Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. J Exp Med 171:449, 1990
8. Clark-Lewis I, Dewald B, Loetscher M, Moser B, Baggiolini M: Structural requirements for interleukin-8 function identified by design of analogs and CXC-chemokine hybrids. J Biol Chem 269:16075, 1994
9. Petersen F, Flad H-D, Brandt E: Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects. J Immunol 152:2467, 1994
10. Beckmann MP, Gayle RB, Cerretti DP, March CJ, Srinivasan S, Sleath PR: Structural and functional characterization of the interleukin-8 receptors, in Lindley IJD, Westwick J, Kunkel S (eds): The Chemokines. New York, NY, Plenum, 1993, p 155
11. Schumacher C, Clark-Lewis I, Baggiolini M, Moser B: High- and low-affinity binding of GROα and neutrophil-activating peptide 2 to interleukin 8 receptors on human neutrophils. Proc Natl Acad Sci USA 89:10542, 1992
12. Moser B, Schumacher C, von Tscharner V, Clark-Lewis I, Baggiolini M: Neutrophil-activating peptide 2 and melanoma growth stimulatory activity interact with neutrophil-activating peptide 1/ interleukin 8 receptors on human neutrophils. J Biol Chem 266:10666, 1991
13. Holmes WE, Lee J, Kuang WJ, Rice GC, Wood WI: Structure and functional expression of a human interleukin-8 receptor. Science 253:1278, 1991
14. Murphy PM, Tiffany HL: Cloning of complementary DNA encoding a functional human interleukin-8 receptor. Science 253:1280, 1991
15. Lowman HB, Slage PH, Deforge LD, Wirth CM, Gillece-Castro BL, Bourell JH, Fairbrother WJ: Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities. J Biol Chem 271:14344, 1996
16. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B: Both interleukin-8 receptors independently mediate chemotaxis: Jurkat cells transfected with IL-8R1 or IL-8R2 migrate in response to IL-8, GROαand NAP-2. FEBS Lett 341:187, 1994
17. LaRosa GJ, Thomas KM, Kaufmann ME, Mark R, White M, Taylor L, Gray G, Witt D, Navarro J: Amino terminus of the interleukin-8 receptor is a major determinant of receptor subtype specificity. J Biol Chem 267:25402, 1992
18. Lee J, Horuk R, Rice GC, Bennett GL, Camerato T, Wood WI: Characterization of two high affinity human interleukin-8 receptors. J Biol Chem 267:16283, 1992
19. Schröder J-M, Mrowietz U, Monta E, Christophers E: Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity. J Immunol 139:3474, 1987
20. Walz A, Dewald B, von Tscharner V, Baggiolini M: Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med 170:1745, 1989
21. Moser B, Clark-Lewis I, Zwahlen R, Baggiolini M: Neutrophil activating properties of the melanoma growth-stimulatory activity. J Exp Med 171:1797, 1990
22. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM: Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to IL-8. J Exp Med 174:1355, 1991
23. 2-terminal amino acid sequence identity with melanoma growth stimulatory activity. J Exp Med 171:1091, 1990
24. i changes and respiratory burst in human neutrophils and monocytes induced by NAP-1/interleukin-8, NAP-2, and gro/ MGSA, J Leukoc Biol 50:279, 1991
25. Magazin M, Vita N, Cavrois E, Lefort S, Guillemot JC, Ferrara P: The biological activities of groβ and IL-8 on human neutrophils are overlapping but not identical. Eur Cytokine Netw 3:461, 1993
26. Detmers PA, Powell DE, Walz A, Clark-Lewis I, Baggiolini M, Cohn ZA: Differential effects of neutrophil-activating peptide 1/ IL-8 and its homologues on leukocyte adhesion and phagocytosis. J Immunol 147:4211, 1991
27. Leonard EJ, Yoshimura T, Rot A, Noer K, Walz A, Baggiolini M, Walz DA, Goetzl EJ, Castor CW: Chemotactic activity and receptor binding of neutrophil attractant/activation protein-1 (NAP-1) and structurally related host defense cytokines: Interaction of NAP-2 with the NAP-1 receptor. J Leukoc Biol 49:258, 1991
28. Derynck R, Balentien E, Han JH, Thomas HG, Wen DZ, Samanta AK, Zachariae CO, Griffin PR, Brachmann R, Wong WL: Recombinant expression, biochemical characterization, and biological activities of the human MGSA/gro protein. Biochemistry 29:10225, 1990
29. Hammond MEW, Lapointe GR, Feucht PH, Hilt S, Gallegos CA, Gordon CA, Giedlin MA, Mullenbach G, Tekamp-Olson P: IL-8 induces neutrophil chemotaxis predominantly via type I IL-8 receptors. J Immunol 155:1428, 1995
30. Wu L, Ruffing N, Shi X, Newman W, Soler D, Mackay CR, Qin S: Discrete steps in binding and signaling of interleukin-8 with its receptor. J Biol Chem 271:31202, 1996
31. Brandt E, Petersen F, Flad H-D: Recombinant tumor necrosis factor-α potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J Immunol 149:1356, 1992
32. Zahn S, Zwirner J, Sprengler H-P, Götze O: Chemoattractant receptors for IL-8 and C5a: Expression on periheral blood leukocytes and differential regulation on HL-60 and AML-193 cells by vitamin D3 and all-trans retinoic acid. Eur J Immunol 27:935, 1997
33. Creamer HR, Gabler WL, Bullock WW: Endogenous component chemotactic assay (ECCA). Inflammation 7:321, 1983
34. Yoshimura T, Matsushima K, Tanaka S, Robinson EA, Appella E, Oppenheim JJ, Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233, 1987
35. Grob PM, David E, Warren TC, DeLeon RP, Farina PR, Homon CA: Characterization of a receptor for human monocyte-derived neutrophil chemotactic factor/interleukin-8. J Biol Chem 265:8311, 1990
36. Petersen F, Ludwig A, Flad HD, Brandt E: TNF-α renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. J Immunol 156:1954, 1996
37. Samanta AK, Oppenheim JJ, Matsushima K: Interleukin 8 (monocyte-derived neutrophil chemotactic factor) dynamically regulates its own receptor expression on human neutrophils. J Biol Chem 265:183, 1990
38. Ahuja SK, Lee JC, Murphy PM: CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B-Determinants of high affinity binding and receptor activitation are distinct. J Biol Chem 271:225, 1996
39. Ehlert JE, Petersen F, Kubbutat MHG, Gerdes J, Had H-D, Brandt E: Limited and defined truncation at the C terminus enhances receptor binding and degranulation activity of the neutrophil-activating peptide 2 (NAP-2). Comparison of native and recombinant NAP-2 variants. J Biol Chem 270:6338, 1995
40. Moser B, Barella L, Mattei S, Schumacher C, Boulay F, Colombo MP, Baggiolini M: Expression of transcripts for two interleukin 8 receptors in human phagocytes, lymphocytes and melanoma cells. Biochem J 294:285, 1993
41. Morohashi H, Miyawaki T, Nomura H, Kuno K, Murakami S, Matsushima K, Mukaida N: Expression of both types of human interleukin-8 receptors on mature neutrophils, monocytes, and natural killer cells. J Leukoc Biol 57:180, 1995
42. Chuntharapai A, Lee J, Hébert CA, Kim KJ: Monoclonal antibodies detect different distribution patterns of IL-8 receptor A and IL-8 receptor B on human peripheral blood leukocytes. J Immunol 153:5682, 1994
43. Ben-Baruch A, Bengali K, Xu L, Oppenheim, JJ. Wang, JM: IL-8 and NAP-2 differ in their capacities to bind and chemoattract 293 cells transfected with either IL-8 receptor type A or type B. Cytokine 9:37, 1997
44. Mueller SG, White JG, Schraw WP, Lam V, Richmond A: Ligand-induced desensitization of the human CXC chemokine receptor-2 is modulated by multiple serine residues in the carboxyl-terminal domain of the receptor. J Biol Chem 272:8207, 1997
45. Gayle RB, Sleath PR, Srinivason S, Briks CW, Weerawarna KS, Cerretti DP, Kozlosky CJ, Nelson N, Bos TV, Beckmann MP: Importance of the amino terminus of the interleukin-8 receptor in ligand interactions. J Biol Chem 10:7283, 1993
46. Cerretti DP, Kozlosky CJ, Vanden Bos T, Nelson N, Gearing DP, Beckmann MP: Molecular characterization of receptors for human interleukin-8, gro/melanoma growth-stimulatory activity and neutrophil activating peptide-2. Mol Immunol 30:359, 1993
47. Ahuja SK, Murphy PM: The CXC chemokines growth-regulated oncogene (GRO)α, GROβ. GROγ, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271:20545, 1996
48. Norgauer J, Metzner B, Schraufstätter I: Expression and growth-promoting function of the IL-8 receptor β in human melanoma cells. J Immunol 156:1132, 1996
49. Jones SA, Wolf M, Qin SX, Mackay CR, Baggiolini M: Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 93:6682, 1996
50. Jones SA, Moser B, Thelen M: A comparison of post-receptor sigfial transduction events in Jurkat cells transfected with either IL-8R1 or IL-8R2: Chemokine mediated activation of p42/p44 MAP-kinase (ERK-2). FEES Lett 364:211, 1995